Unknown

Dataset Information

0

Characterization and solution structure of the factor VIII C2 domain in a ternary complex with classical and non-classical inhibitor antibodies.


ABSTRACT: The most significant complication for patients with severe cases of congenital or acquired hemophilia A is the development of inhibitor antibodies against coagulation factor VIII (fVIII). The C2 domain of fVIII is a significant antigenic target of anti-fVIII antibodies. Here, we have utilized small angle x-ray scattering (SAXS) and biochemical techniques to characterize interactions between two different classes of anti-C2 domain inhibitor antibodies and the isolated C2 domain. Multiple assays indicated that antibodies 3E6 and G99 bind independently to the fVIII C2 domain and can form a stable ternary complex. SAXS-derived numerical estimates of dimensional parameters for all studied complexes agree with the proportions of the constituent proteins. Ab initio modeling of the SAXS data results in a long kinked structure of the ternary complex, showing an angle centered at the C2 domain of ?130°. Guided by biochemical data, rigid body modeling of subunits into the molecular envelope of the ternary complex suggests that antibody 3E6 recognizes a C2 domain epitope consisting of the Arg(2209)-Ser(2216) and Leu(2178)-Asp(2187) loops. In contrast, antibody G99 recognizes the C2 domain primarily through the Pro(2221)-Trp(2229) loop. These two epitopes are on opposing sides of the fVIII C2 domain, are consistent with the solvent accessibility in the context of the entire fVIII molecule, and provide further structural detail regarding the pathogenic immune response to fVIII.

SUBMITTER: Walter JD 

PROVIDER: S-EPMC3617290 | biostudies-literature | 2013 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Characterization and solution structure of the factor VIII C2 domain in a ternary complex with classical and non-classical inhibitor antibodies.

Walter Justin D JD   Werther Rachel A RA   Polozova Maria S MS   Pohlman Julie J   Healey John F JF   Meeks Shannon L SL   Lollar Pete P   Spiegel P Clint PC  

The Journal of biological chemistry 20130215 14


The most significant complication for patients with severe cases of congenital or acquired hemophilia A is the development of inhibitor antibodies against coagulation factor VIII (fVIII). The C2 domain of fVIII is a significant antigenic target of anti-fVIII antibodies. Here, we have utilized small angle x-ray scattering (SAXS) and biochemical techniques to characterize interactions between two different classes of anti-C2 domain inhibitor antibodies and the isolated C2 domain. Multiple assays i  ...[more]

Similar Datasets

| S-EPMC3868927 | biostudies-literature
| S-EPMC8223065 | biostudies-literature
| S-EPMC2838304 | biostudies-literature
| S-EPMC3670696 | biostudies-literature
| S-EPMC4657047 | biostudies-literature
| S-EPMC4361576 | biostudies-literature
| S-EPMC8663028 | biostudies-literature
| S-EPMC2919080 | biostudies-literature
| S-EPMC3947443 | biostudies-literature
| S-EPMC8160500 | biostudies-literature